These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Why Has a Run-In Period Been a Design Element in Most Landmark Clinical Trials? Analysis of the Critical Role of Run-In Periods in Drug Development. Packer M J Card Fail; 2017 Sep; 23(9):697-699. PubMed ID: 28760644 [TBL] [Abstract][Full Text] [Related]
3. Commentary on the use of run-in periods in clinical trials. Franciosa JA Am J Cardiol; 1999 Mar; 83(6):942-4, A9. PubMed ID: 10190414 [TBL] [Abstract][Full Text] [Related]
4. Innovative Clinical Trial Designs for Precision Medicine in Heart Failure with Preserved Ejection Fraction. Shah SJ J Cardiovasc Transl Res; 2017 Jun; 10(3):322-336. PubMed ID: 28681133 [TBL] [Abstract][Full Text] [Related]
5. [Design of clinical studies: new approaches beyond randomised investigations]. Nienaber CA; Willems S; Erdmann E Dtsch Med Wochenschr; 2014 Sep; 139(39):1921-2. PubMed ID: 25225859 [No Abstract] [Full Text] [Related]
7. Design considerations and proposed template for clinical trials in hospitalized patients with decompensated chronic heart failure. O'Connor CM; Gattis WA; Teerlink JR; Adams KF; Gheorghiade M Am Heart J; 2003 Feb; 145(2 Suppl):S47-50. PubMed ID: 12594451 [No Abstract] [Full Text] [Related]
8. The failure of the ACCLAIM trial is due to an irrational technology. Bocci V Int J Cardiol; 2010 Mar; 139(3):304-5. PubMed ID: 18996606 [TBL] [Abstract][Full Text] [Related]
10. Direct effect on validity of response run-in selection in clinical trials. Berger VW; Rezvani A; Makarewicz VA Control Clin Trials; 2003 Apr; 24(2):156-66. PubMed ID: 12689737 [TBL] [Abstract][Full Text] [Related]
11. Comparison of clinical trials evaluating cardiac resynchronization therapy in mild to moderate heart failure. Zaręba W Cardiol J; 2010; 17(6):543-8. PubMed ID: 21154255 [TBL] [Abstract][Full Text] [Related]
12. Characteristics of cluster randomized trials: are they living up to the randomized trial? Selvaraj S; Prasad V JAMA Intern Med; 2013 Feb; 173(4):313-5. PubMed ID: 23337957 [No Abstract] [Full Text] [Related]
13. Do heart failure trials need an end point committee? Ghali JK Am Heart J; 2010 Oct; 160(4):571-3. PubMed ID: 20934548 [No Abstract] [Full Text] [Related]
14. Global Variations in Patient Populations and Outcomes in Heart Failure Clinical Trials. Egwim C; Dixon B; Ambrosy AP; Mentz RJ Curr Heart Fail Rep; 2017 Feb; 14(1):30-39. PubMed ID: 28185163 [TBL] [Abstract][Full Text] [Related]
15. [Extrapolation of results from clinical trials to heart failure patients hospitalized in Internal Medicine]. Conde Martel A Med Clin (Barc); 2014 May; 142(10):463-7. PubMed ID: 24022030 [No Abstract] [Full Text] [Related]
16. In support of more clustered randomized trials. O'Malley PG JAMA Intern Med; 2013 Feb; 173(4):315. PubMed ID: 23338562 [No Abstract] [Full Text] [Related]
17. Lessons learned from clinical trials in acute heart failure: phase 3 drug trials. O'Connor CM; Fiuzat M Heart Fail Clin; 2011 Oct; 7(4):451-6. PubMed ID: 21925428 [TBL] [Abstract][Full Text] [Related]
18. Design of randomized controlled trials. Stanley K Circulation; 2007 Mar; 115(9):1164-9. PubMed ID: 17339574 [No Abstract] [Full Text] [Related]
19. Treatment allocation in clinical trials. Webert KE Transfusion; 2007 Dec; 47(12):2187-8. PubMed ID: 17714423 [No Abstract] [Full Text] [Related]
20. [Ultrafiltration in acute decompensated heart failure: Sunset Boulevard?]. Fiaccadori E G Ital Nefrol; 2013; 30(1):. PubMed ID: 25083528 [No Abstract] [Full Text] [Related] [Next] [New Search]